Publication | Open Access
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
137
Citations
17
References
2019
Year
NCT02559310.
| Year | Citations | |
|---|---|---|
Page 1
Page 1